Immunome (IMNM) Free Cash Flow (2019 - 2026)
Immunome (IMNM) posted Free Cash Flow of -$61.6 million for Q1 2026, down 18.65% on a QoQ basis from -$52.0 million in Q4 2025, and down 8.67% year-over-year from -$67.5 million in Q1 2025.
Immunome (IMNM) Free Cash Flow (2019 - 2026) Analysis & Trends
Immunome's Free Cash Flow history runs 8 years deep, the most recent figure standing at -$61.6 million for Q1 2026.
- Quarterly Free Cash Flow fell 8.67% year-over-year to -$61.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$205.5 million (down 26.15% YoY) and the FY2025 annual result came in at -$200.6 million, down 70.05% from the prior year.
- Free Cash Flow was -$61.6 million for Q1 2026 at Immunome, down from -$52.0 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $24.0 million in Q1 2023 and bottomed at -$61.6 million in Q1 2026.
- A 5-year average of -$24.5 million and a median of -$17.5 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow jumped 475.27% — and 2025, when it tumbled 382.15%.
- Immunome's Free Cash Flow stood at -$6.8 million in 2022, then plunged by 159.3% to -$17.5 million in 2023, then sank by 146.55% to -$43.2 million in 2024, then retreated by 20.3% to -$52.0 million in 2025, then slipped by 18.65% to -$61.6 million in 2026.
- Business Quant data shows IMNM's Free Cash Flow at -$61.6 million in Q1 2026, -$52.0 million in Q4 2025, and -$44.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.95 Mn |
| 10 | Immunome | 2.51 Bn | 1.93 Bn | - | -61.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.64 Mn |
| Mar 31, 2026 | -61.64 Mn |
| Dec 31, 2025 | -51.95 Mn |
| Dec 31, 2025 | -51.95 Mn |
| Sep 30, 2025 | -44.91 Mn |
| Sep 30, 2025 | -44.91 Mn |
| Jun 30, 2025 | -47.02 Mn |
| Jun 30, 2025 | -47.02 Mn |
| Mar 31, 2025 | -56.72 Mn |
| Mar 31, 2025 | -56.72 Mn |
| Dec 31, 2024 | -43.19 Mn |
| Dec 31, 2024 | -43.19 Mn |
| Sep 30, 2024 | -35.71 Mn |
| Sep 30, 2024 | -35.71 Mn |
| Jun 30, 2024 | -27.31 Mn |
| Jun 30, 2024 | -27.31 Mn |
| Mar 31, 2024 | -11.76 Mn |
| Mar 31, 2024 | -11.76 Mn |
| Dec 31, 2023 | -17.52 Mn |
| Dec 31, 2023 | -17.52 Mn |